Management of Right Upper Lobe Nodule and Left Carotid Artery Stenosis

Management of 1.0 cm Right Upper Lobe Nodule

The American College of Radiology suggests that a 1.0 cm non-FDG-avid right upper lobe nodule along the minor fissure strongly favors a benign etiology, with non-FDG-avid solid nodules of this size frequently being benign in origin, often representing healed granulomata from previous infections or intrapulmonary lymph nodes 1, 2
The lack of FDG uptake is particularly reassuring, as malignant nodules typically accumulate FDG, though rare exceptions exist with well-differentiated adenocarcinomas and bronchioloalveolar cell carcinomas, as noted by the Journal of the American College of Radiology 3
For a solitary solid noncalcified nodule of this size (1.0 cm) without FDG avidity, imaging surveillance is the appropriate management strategy, with follow-up imaging to be performed with low-radiation dose CT technique to minimize cumulative radiation exposure, as recommended by Radiology 1, 3, 4
Follow-up CT examinations should use contiguous thin sections (≤1.5 mm, typically 1.0 mm) to enable accurate characterization and measurement during follow-up, with follow-up CT at 6-12 months being appropriate for a 1.0 cm solid nodule with low suspicion features (non-FDG-avid) 1, 2, 4

The European Heart Journal recommends that dense carotid calcification with probable stenosis of the left carotid artery requires further evaluation, with Doppler ultrasound (DUS) being the first-line imaging modality to evaluate the severity of carotid stenosis 5, 6
DUS is the preferred initial test to quantify the degree of stenosis and should be performed promptly, with additional imaging with CTA or MRA being appropriate if DUS results are inconclusive or equivocal, as suggested by the Journal of the American College of Cardiology 5, 6
If significant stenosis (70-99%) is confirmed in the symptomatic carotid artery, carotid endarterectomy (CEA) should be considered, provided the procedural risk of stroke/death is <6%, with medical therapy alone being recommended for non-significant stenosis (<50%) 5, 6
Optimal medical therapy should be initiated regardless of the degree of stenosis, including aggressive control of cardiovascular risk factors such as hypertension and hypercholesterolemia, with annual follow-up being recommended to assess cardiovascular risk factors and treatment compliance 5